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A B S T R A C T   
Background: Whereas several predictors of COVID-19 vaccine hesitancy have been reported, the role of cognitive 
function is largely unknown. Accordingly, our objective was to evaluate the association between scores from an 
array of cognitive function tests and self-reported vaccine hesitancy after the announcement of the successful 
testing of the first COVID-19 vaccine (Oxford University/AstraZeneca). 
Methods: We used individual-level data from a pandemic-focused study (’COVID Survey’), a prospective cohort 
study nested within United Kingdom Understanding Society (’Main Survey’). In the week immediately following 
the announcement of successful testing of the first efficacious inoculation (November/December 2020), data on 
vaccine intentionality were collected in 11,740 individuals (6702 women) aged 16–95 years. Pre-pandemic 
scores on general cognitive function, ascertained from a battery of six tests, were captured in 2011/12 wave 
of the Main Survey. Study members self-reported their intention to take up a vaccination in the COVID-19 
Survey. 
Results: Of the study sample, 17.2% (N = 1842) indicated they were hesitant about having the vaccine. After 
adjustment for age, sex, and ethnicity, study members with a lower baseline cognition score were markedly more 
likely to be vaccine hesitant (odds ratio per standard deviation lower score in cognition; 95% confidence interval: 
1.76; 1.62, 1.90). Adjustment for mental and physical health plus household shielding status had no impact on 
these results, whereas controlling for educational attainment led to partial attenuation but the probability of 
hesitancy was still elevated (1.52; 1.37, 1.67). There was a linear association for vaccine hesitancy across the full 
range of cognition scores (p for trend: p < 0.0001). 
Conclusions: Erroneous social media reports might have complicated personal decision-making, leading to people 
with lower cognitive ability being vaccine-hesitant. With individuals with lower cognition also experiencing 
higher rates of COVID-19 in studies conducted prior to vaccine distribution, these new findings are suggestive of 
a potential additional disease burden.   
1. Introduction 
Cognitive function – also known as mental ability or intelligence – 
refers to psychological functions that involve the storage, selection, 
manipulation, and organisation of information, and the planning of 
actions (Deary, 2012; Deary and Batty, 2007). Assessed using standard 
tests, there is marked inter-person variation in how rapidly and precisely 
people carry out these mental tasks (Deary, 2012; Deary and Batty, 
2007). Health protection and health care can also be regarded as a 
complex set of assignments that require assimilation of knowledge, 
decision-making, and planning. It has been posited that people with 
higher cognitive function manage preventative behaviours and treat-
ment more effectively (Gottfredson, 2004), and there is growing evi-
dence that this is the case. 
In well-characterised cohort studies, relative to their lower- 
performing counterparts, people with higher ability are more likely to 
have a healthy diet (Batty et al., 2007b), choose dietary supplements 
(Whalley et al., 2003), and be physically active (Batty et al., 2007b). 
Those who score better on cognitive tests also have a lower probability 
of smoking cigarettes (Batty et al., 2007a, 2007c), drinking harmful 
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levels of alcohol (Batty et al., 2006), and having associated problems 
(Batty et al., 2008). Cessation rates are also elevated in smokers with 
higher mental ability Taylor et al., 2005). Further, in individuals with a 
greater risk of a first cardiovascular disease event (Deary et al., 2009), in 
those with a higher probability of re-infarction,(Wallert et al., 2017) and 
in patients with respiratory disease (O’Conor et al., 2019), improved 
compliance with known efficacious drug therapies is apparent with 
higher ability scores. Similarly, in people with an elevated risk of 
colorectal cancer, rates of participation in a free screening programme 
were elevated in persons with better performance on tests of cognition 
(Gale et al., 2015). 
These observations provide circumstantial evidence for a link be-
tween cognitive ability and another health-protecting behaviour, vac-
cine uptake. Vaccination is central to controlling the present pandemic, 
with success reliant on a sufficiently high uptake to achieve herd im-
munity (Omer et al., 2020). In the only empirical investigation of which 
we are aware, a very brief measure of analytical reasoning was admin-
istered to people in two small cross-sectional studies from the UK (N =
2025) and Ireland (N = 1041) (Murphy et al., 2021). Relative to the 
group who indicated they would be likely to accept a COVID-19 inoc-
ulation if one became available, somewhat lower cognition scores were 
apparent in study members indicating vaccine reticence (Murphy et al., 
2021). These data were collected in March/April 2020 when no effica-
cious vaccine had been tested. Around 8 months later, following peri-
odic statements to the media of its on-going development, successful 
testing of the Oxford University/AstraZeneca vaccine, the first known 
efficacious inoculation against COVID-19, was announced (Gallacher, 
2020). Time-series analyses across multiple countries potentially im-
plicates this declaration and those for other vaccines in having a positive 
impact upon intentionality (YouGov, 2021). Accordingly, for the first 
time to our knowledge, we investigated the link between cognitive 
function and COVID-19 vaccine hesitancy in a large UK general 
population-based sample in which data collection took place following 
the announcement of an efficacious vaccine. 
2. Methods 
Understanding Society, also known as the United Kingdom House-
hold Longitudinal Study, is a nationally-representative, on-going, open, 
cohort study (hereinafter, the ‘Main Survey’) (University of Essex, 
2020). Based on a clustered-stratified probability sample of households, 
participants have been interviewed annually since 2009. Households 
who had participated in at least one of the two most recent waves of data 
collection (wave 8, 2016–18; wave 9, 2017–19) comprised the target 
sample for a pandemic-focused study initiated in April 2020 (herein-
after, the ‘COVID Survey’) (University of Essex, 2021). The derivation of 
the present analytical sample from the Main and COVID surveys, 
including the wave in which relevant data were collected, is depicted in 
Fig. 1. The University of Essex Ethics Committee gave approval for data 
collection in the COVID-orientated surveys (ETH1920-1271); no further 
ethical permissions were required for the present analyses of anony-
mised data. 
The COVID Surveys took place monthly/bimonthly between April 
(wave 1) and, at the time of analyses, November 2020 (wave 6), with 
questions on vaccine intention first administered in the November wave 
when study members were aged 16–95 years (mean 53). Data collection 
in wave 6 (starting 24th November) commenced the day immediately 
following the announcement of the efficacy of the Oxford University/ 
AstraZeneca vaccine (Gallacher, 2020) and continued for one week, 
comprising a total of 12,035 individuals of 19,294 invitations issued 
(response proportion, 62%). 
2.1. Assessment of cognitive function 
In the third wave of data collection in the Main Survey (2011–2013), 
six cognitive function tests were administered following piloting (Gray 
et al., 2011; McFall, 2013). Representing a range of cognitive skills, 
these tests have been repeatedly deployed in large-scale, population- 
based studies (Borsch-Supan et al., 2013; Lachman et al., 2010; Richards 
et al., 2004; Sonnega et al., 2014; Steptoe et al., 2013). Verbal declar-
ative memory was assessed using both immediate word recall and delayed 
word recall tasks. Respondents listened to a list of ten words delivered by 
a computer; they were then asked to immediately recall the words and, 
again, at a later stage in the interview without having heard the words 
again. The number of correct responses was recorded on each occasion. 
For semantic verbal fluency, respondents named as many animals as they 
could in one minute; the final score was based on the number of unique 
correct responses. Using components of screening instruments for 
cognitive impairment including the Mini Mental State Examination (Crum 
et al., 1993) and the Cambridge Cognitive Examination (Huppert et al., 
1995), respondents were asked to subtract 7 from 100 and then subtract 
7 from their answer on four more occasions. The number of correct re-
sponses of a maximum of five was recorded. Fluid reasoning was assessed 
using a number sequence in which the respondent populated the gap(s) 
in a logical series. Respondents were initially presented with simple 
examples to test their understanding; those who seemed confused or 
unable to understand test requirements after the relaying of two ex-
amples were excused from the test. Remaining study members were 
administered two sets of three number sequences, with the difficulty of 
the second set determined by their performance on the first. A score was 
derived which accounts for the difficulty of the items. Lastly, for nu-
merical reasoning skills, individuals were given three numerical problems 
Fig. 1. Flow of cohort members into the analytical sample: Main Survey and 
COVID Survey in Understanding Society 
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to solve and, depending on their responses, were then administered a 
further one (simpler) or two (more difficult) problems. The total number 
of correct responses was recorded. 
2.2. Assessment of covariates 
Covariates were self-reported and included age; sex (both wave 10 
[2019–20], Main Survey); ethnicity (wave 10, Main Survey; denoted as 
white or non-white); highest education level (wave 10, Main Survey; 
categorised as degree & other higher degree, A’ level or equivalent 
[Advanced Placement in the US], GCSE or equivalent [Grade 10 in the 
USA], other qualification, and none); and National Health Service- 
recommended shielding status for any household member (waves 1–5 
[April-September 2020], COVID Surveys; denoted by yes/no). A history 
of physical morbidities was also captured (wave 10, Main Survey) and 
based on any mention of a cardiometabolic condition (congestive heart 
failure, coronary heart disease, angina, heart attack or infarction, stroke, 
diabetes, and/or hypertension); respiratory disease (respiratory disease 
comprised bronchitis, emphysema, chronic obstructive pulmonary dis-
ease, and/or asthma); or cancer of any type. Current psychological 
distress (wave 6 [November 2020], COVID Survey) was ascertained 
using the administration of the 12-item version of the General Health 
Questionnaire. Validated against standardised psychiatric interviews 
(Hankins, 2008; Holi et al., 2003), this is a widely used measure of 
distress (anxiety and depression) in population-based studies. Consistent 
with published analyses (Russ et al., 2011, 2015, 2012), we used a score 
of ≥ 3 to denote psychological distress. 
2.3. Assessment of vaccine intentionality 
At wave 6 in the COVID Survey, study members were asked “Imagine 
that a vaccine against COVID-19 was available for anyone who wanted 
it. How likely or unlikely would you be to take the vaccine?”. Possible 
responses were “Very likely”, “Likely”, “Unlikely” and “Very unlikely”. 
The latter two categories were combined to denote vaccine hesitancy. 
3. Statistical analyses 
It is well-replicated that performance on tests of cognitive abilities 
are positively inter-related, whereby people who score highly on one test 
of cognition tend to score well on another (Deary, 2012). This has led to 
the use of the term ‘general cognitive ability’, usually known as ‘g’. 
Accordingly, using scores from the six tests of cognitive function we 
generated a single general cognitive function variable. Computed using 
principal components analysis, the first unrotated component of the six 
cognitive tests was used as a single measure of cognitive function 
(variance explained: 42%; loadings: immediate recall 0.74, delayed 
recall 0.72, verbal fluency 0.59, serial sevens 0.49, number series 0.64, 
numerical problem solving 0.66). To summarise the relation between 
cognition and vaccine hesitancy, we used logistic regression to compute 
odds ratios with accompanying 95% confidence intervals. In these an-
alyses we calculated effect estimates for tertiles of cognitive function 
scores (highest was the referent group) and those for a unit (standard 
deviation) disadvantage in score. The most basic analyses were adjusted 
for age, sex, and ethnicity. Retaining these covariates, we then explored 
the impact of separately controlling for existing somatic medical con-
ditions, mental health, education, and shielding status. 
4. Results 
In a sample of 11,955 individuals who responded in full to the 
enquiry regarding COVID-19 vaccine intentionality, 17.2% (N = 1842) 
indicated that they were hesitant. In Table 1 we show unadjusted study 
member characteristics according to vaccine intention. Relative to the 
group who indicated a willingness to have the vaccine, those who were 
hesitant were more likely to be young, female, from an ethnic minority 
background, and be less well educated. The hesitant were also less likely 
to carry an array of existing somatic morbidities and be shielding or live 
with someone who was. The prevalence of psychological distress was 
somewhat higher in the vaccine hesitant. 
There were also differences in cognitive function between the vac-
cine groups, whereby the vaccine hesitant study members had lower 
general ability scores (difference in mean score 3.9; p-value for differ-
ence: <0.0001). We investigated these differentials in more detail in 
Table 2 where we present the results of regression analyses incorpo-
rating potential explanatory variables in an analytical sample of 7361 
people with full data for all the variables depicted; that is, a non-missing 
dataset (Fig. 1). In age-, sex- and ethnicity-adjusted analyses, a one 
standard deviation lower score in general cognitive ability was associ-
ated with a 76% greater risk of being vaccine hesitant (odds ratio; 95% 
confidence interval: 1.76; 1.62, 1.90). While separate adjustments for 
somatic comorbidity, psychological distress, and shielding had no 
impact on this relationship, adjustment for education led to some 
attenuation (1.52; 1.37, 1.67) – the Kendall rank correlation between 
cognition and educational attainment was 0.27 (p < 0.0001). Simulta-
neous adjustment for all covariates had no greater attenuating effect 
than the adjustment for education alone. 
To gain insights into whether the association with vaccine hesitancy 
was linear, the analyses were repeated according to tertiles of cognitive 
function. In age-, sex- and ethnicity- adjusted analyses, relative to people 
in the highest-scoring cognition tertile, those in the lowest were twice as 
likely to be vaccine hesitant (1.99; 1.66, 2.40). People in the interme-
diate ability tertile had intermediate risk of hesitancy (1.28; 1.07, 1.54) 
such that an incremental effect was apparent across the cognition cat-
egories (p-value for trend: <0.0001). To explore the impact on loss to 
follow-up, we derived inverse probability weights. Repeating our main 
analyses, our results were essentially unchanged (Table 1a, appendix). 
Lastly, in order to explore inflections in the cognition–hesitancy as-
sociation, we utilised deciles of cognition in analyses. Again, there was 
evidence of a clear trend, although this was not perfectly stepwise across 
all categories (Fig. 2). 
Table 1 
Study member characteristics according to COVID-19 vaccine hesitancy in Un-
derstanding Society   
Vaccine hesitant P value for 
difference 
Yes No 





Demographic factors    
Age, yr, mean (SD) 45.0 
(14.5) 
54.6(15.6) <0.0001 
Female, N (%) 1162 (63) 5530 (55) <0.0001 
Non-white ethnicity, N (%) 406 (22.0) 698 (7.0) <0.0001  
Socioeconomic factors    
No university education, N (%) 939 (51.0) 4298 (42.5) <0.0001  
Comorbidities    
Cardiometabolic disease, N 
(%) 
268 (15.0) 2513 (25.2) <0.0001 
Respiratory disease, N (%) 219 (12.3) 1372 (13.8) 0.144 
Any cancer, N (%) 45 (2.5) 525 (5.3) <0.0001 
High psychological distress, N 
(%) 
509 (27.6) 2399 (23.7) <0.0001 
Shielding in the household, N 
(%) 
196 (10.6) 1187 (11.7) <0.0001  
Cognitive function    
g factor, mean (SD) 96.6 
(15.7) 
100.5 (14.8) <0.0001 
Numbers of study members corresponds to those with complete data 
on vaccine intentionality 
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5. Discussion 
5.1. Principal findings 
Our main finding was that, in data collected immediately following 
the announcement in the UK of an efficacious vaccine, and net of several 
covariates, people with lower scores on tests of cognitive function were 
less minded to take up an offer of vaccination for COVID-19 if it was 
made. These effects were apparent across the full range of cognition 
scores. That we were able to replicate known predictors of COVID-19 
vaccine hesitancy – being female (Detoc et al., 2020; Freeman et al., 
2020; Wang et al., 2020), younger (Detoc et al., 2020; Freeman et al., 
2020), non-white ethnicity,(Freeman et al., 2020; Robertson et al., 
2021; Williams et al., 2021), and having a lower prevalence of physical 
morbidity(Ruiz and Bell, 2021) – gives us some confidence in our novel 
results for cognitive function. 
5.2. Comparison with existing studies 
To the best of our knowledge, as described, there has been one prior 
examination of the relationship between cognition and vaccine hesti-
nacy (Murphy et al., 2021). Comprising two small cross-sectional studies 
where data collection took place before the announcement of vaccine 
test results, people who performed better on a short test of cognitive 
function were more likely to be vaccine-accepting (Murphy et al., 2021). 
We found similar results in using more detailed measures of cognitive 
function in a large sample which allowed us to explore the shape of the 
relationship across the full range of abilities. A closely related literature 
Table 2 
Odds ratios (95% confidence interval) for the relation of general cognitive function with COVID-19 vaccine hesitancy in Understanding Society   
Number hesitant/ 
Total at risk 
Age, sex, & 
ethnicity 
Age, sex, ethnicity, & 
somatic comorbidity 
Age, sex, ethnicity, & 
psychological distress 
Age, sex, ethnicity, 
& shielding 






236/2284 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 
Tertile 2 352/2918 1.28 (1.07, 
1.54) 
1.29 (1.08, 1.55) 1.28 (1.07, 1.54) 1.29 (1.08, 1.55) 1.17 (0.98, 1.41) 1.18 (0.99, 
1.42) 
Tertile 1 365/2159 1.99 (1.66, 
2.40) 
2.01 (1.67, 2.43) 1.99 (1.66, 2.40) 2.01 (1.67, 2.42) 1.64 (1.35, 1.99) 1.67 (1.37, 
2.03) 
P for trend  p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 p < 0.0001 
Per SD 
decrease 
953/7361 1.76 (1.62, 
1.90) 
1.77 (1.63, 1.91) 1.76 (1.62, 1.90) 1.78 (1.64, 1.91) 1.52 (1.37, 1.67) 1.54 (1.40, 
1.69) 
Numbers of study members in this sample corresponds to those with complete data on all variables in the analyses. Thresholds for categories of cognitive function: 
tertile 1 (>=108.3); tertile 2 (108.2–93.3); and tertile 1 (>=93.2). A standard deviation (SD) in general cognitive function was 15 units. 
Fig. 2. Odds ratios (95% CI) for the relation of general cognitive function with COVID-19 vaccine hesitancy in Understanding Society  
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is that for education with which cognition is positively correlated 
(Neisser et al., 1996). This supports the present results whereby people 
with higher educational achievement were less likely to be vaccine- 
hesitant (Kuter et al., 2021; Nguyen et al., 2021). 
5.3. Potential public health implications 
We have recently shown that, in data collected prior to vaccine 
distribution, of a range of baseline psychosocial factors which included 
socioeconomic status, education, personality type, and mental health, 
cognitive function was the most strongly and robustly associated with 
subsequent incidence of severe COVID-19, such that a doubling of the 
risk of hospitalisation was apparent in the lowest scoring group (Batty 
et al., 2020a). This supports other data that individuals with higher 
cognitive function experience a lower risk of death from other respira-
tory diseases, including influenza and pneumonia (Gale et al., 2019). 
The notion that people with lower cognitive ability appear to have 
greater rates of severe COVID-19 (Batty et al., 2021a, 2020a) and, based 
on the present results are also less likely to take up the offer of vacci-
nation, may further increase the disease burden in this group, as may 
also be the case for people from ethnic minority groups (Lassale et al., 
2020; Robertson et al., 2021) and the socioeconomically disadvantaged 
(Batty et al., 2020a; Murphy et al., 2021). 
5.4. Plausible explanations 
Various explanations may be germane to the cognition–vaccine 
intention link, including the observation that people with higher 
cognitive ability are better equipped to obtain, process, and respond to 
disease prevention advice (von Wagner et al., 2009). There has been a 
deluge of health advice in the current pandemic during an era when 
news outlets and social media platforms have never been more ubiqui-
tous and influential. Preventative information has ranged from the 
simple and practical to the complex, contradictory, false, and fraudu-
lent. In order to diminish their risk of the infection, people have to ac-
quire, synthesise, weigh-up, and deploy this information but the ability 
to do so seems to vary by levels of health literacy (Wolf et al., 2020) just 
as it may for its close correlate, cognitive function. 
5.5. Study strengths and weaknesses 
While the present study has its strengths, including its size, national 
representativeness, and timing, there are also some weaknesses. First, 
we used vaccine intentionality as an indicator vaccine uptake but the 
correlation is imperfect. In a small scale longitudinal study conducted 
during the period of the 2009 H1N1 pandemic in Hong Kong, <10% of 
people who expressed a commitment to being inoculated reported that 
they had received a vaccination two months later (Liao et al., 2011). 
Elsewhere, in a US adult population at high risk of seasonal influenza, 
around half of those intending to be vaccinated had received the inoc-
ulation within the following 5 months (Harris et al., 2009). Second, 
there was inevitably some loss to follow-up (Fig. 1). While this attrition 
may have impacted upon the estimation of the prevalence vaccine 
hesitancy which is likely to be lower in our select sample relative to the 
general population (Fry et al., 2017), it is unlikely to have influenced our 
estimation of its relationship with cognitive function. Thus, in other 
contexts, we have shown that highly select cohorts reveal very similar 
risk factor–disease associations to those seen in studies with conven-
tionally high response (Batty et al., 2020b). Also, as we have shown in 
sensitivity analyses, weighting had very little impact on the relation 
between cognitive function and vaccine hesitancy. Third, the 10 years 
period between cognitive testing and ascertainment of vaccine hesitancy 
raises concerns regarding the impact of changes in cognition function. 
While there was no retesting of cognition in the present study, findings 
from other studies suggest that cognitive function, even in older adults, 
is stable over a 10 year period, and, related, little mean decline will take 
place (Ritchie et al., 2019). Even less decline will have occurred in the 
present sample given that the age continuum covers all adulthood. There 
would also be modest inter-individual differences, such that people 
would largely retain their ranking from baseline. For context, all pop-
ulation characteristics are subject to some variation over time and 
cognition is no exception. As we have shown (Batty et al., 2021), in 
resurveys of samples of up to 31,000 individuals in UK Biobank, 
cognitive function scores (r = 0.63, p < 0.001, N = 9689) have com-
parable test–retest correlation coefficients compared with cigarette 
smoking (0.60, p < 0.001, N = 31,037), blood pressure (0.65, p < 0.001, 
N = 19,772), and diabetes (r = 0.63, P < 0.001, N = 31,037). As has 
been demonstrated (Clarke et al., 1999), this order of correlation may 
result in regression dilution that is likely to lead to underestimation of 
risk factor associations. 
In conclusion, people with lower scores on standard tests of cognitive 
function reported being less willing to take up the future offer of 
vaccination for COVID-19. It is possible that erroneous social media 
news reports have complicated decision-making. Special efforts should 
be made to communicate clear information about vaccine efficacy and 
safety so that everyone—including those who report being less likely to 
choose vaccination—can make well-informed choices. 
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